
LINK . SPRINGER . COM {
}
Title:
Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma | Supportive Care in Cancer
Description:
Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of life in RRMM patients. The cross-sectional study included 184 MM patients (141 RRMM cases and 43 MM patients on follow-up without diagnosis/treatment of RRMM disease as controls), while 64 RRMM patients also provided longitudinal patient-reported outcomes (PROs) data. Symptomatic status was based on clinical measures of disease activity. PROs included the MD Anderson Symptom Inventory multiple myeloma module (MDASI-MM), single-item quality of life (SIQOL), and EuroQol-5D (EQ-5D). Wilcoxon rank test and effect size were used for comparisons. Regression models were used to describe symptom trajectory and to identify predictors of high symptom burden during 3 months of RRMM therapy. Most patients were clinically identified as symptomatic (93%). RRMM patients tended to report more severe symptoms, with significantly lower QOL scores and more severe fatigue, poor appetite, and lower enjoyment of life compared with controls (all p < 0.05). In RRMM patients, lower hemoglobin and higher B-2 microglobulin levels significantly correlated with higher burdens of fatigue, pain, and muscle weakness and also with lower QOL and EQ-5D scores (all p < 0.05). During RRMM therapy, being female, with any comorbidity, ≥ 65 years old, and ≥ 5 years MM history, contributed to high symptoms burden and poor QOL status (each p < 0.05). MDASI-MM modules were sensitive to detect the RRMM-related symptoms burden, which correlated with objective clinical measures. RRMM patients reported a more compromised QOL.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Health & Fitness
- Dating & Relationships
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure if the website is profiting.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
article, myeloma, pubmed, multiple, google, scholar, patients, cancer, life, quality, symptom, cas, study, rrmm, anderson, healthrelated, oncol, relapsed, clin, burden, refractory, outcomes, clinical, review, care, wang, dexamethasone, httpsdoiorgjco, van, central, impact, cleeland, patientreported, symptoms, access, haematol, bortezomib, privacy, cookies, content, data, symptomatic, orlowski, treatment, survival, med, httpsdoiorgjx, information, publish, research,
Topics {✒️}
month download article/chapter org/professionals/physician_gls/pdf/myeloma relapse/refractory multiple myeloma assess clinical decision-making population-based profiles registry relapsed/refractory multiple myeloma mapping eortc qlq-c30 gov/statfacts/html/mulmy patient-reported outcomes real-world treatment patterns article supportive care anderson symptom inventory health/national cancer institution araceli garcia-gonzalez & charles rrmm-related symptoms burden full article pdf refractory multiple myeloma van der holt melphalan refractory myeloma siegel ds privacy choices/manage cookies describe symptom burden high symptom burden related subjects relapsed multiple myeloma van de velde araceli garcia-gonzalez single-center experience placebo-controlled trial stable multiple myeloma stewart ak individual participants included describe symptom trajectory assessing symptom distress bristol-myers squibb bmc cancer 16 recombinant human erythropoietin oral ixazomib global clinical management health-related quality health-related quality high symptoms burden multiple myeloma patients advanced multiple myeloma author information authors de la loge cleeland cs article kamal symptom research european economic area
Schema {🗺️}
WebPage:
mainEntity:
headline:Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma
description:Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of life in RRMM patients. The cross-sectional study included 184 MM patients (141 RRMM cases and 43 MM patients on follow-up without diagnosis/treatment of RRMM disease as controls), while 64 RRMM patients also provided longitudinal patient-reported outcomes (PROs) data. Symptomatic status was based on clinical measures of disease activity. PROs included the MD Anderson Symptom Inventory multiple myeloma module (MDASI-MM), single-item quality of life (SIQOL), and EuroQol-5D (EQ-5D). Wilcoxon rank test and effect size were used for comparisons. Regression models were used to describe symptom trajectory and to identify predictors of high symptom burden during 3 months of RRMM therapy. Most patients were clinically identified as symptomatic (93%). RRMM patients tended to report more severe symptoms, with significantly lower QOL scores and more severe fatigue, poor appetite, and lower enjoyment of life compared with controls (all p < 0.05). In RRMM patients, lower hemoglobin and higher B-2 microglobulin levels significantly correlated with higher burdens of fatigue, pain, and muscle weakness and also with lower QOL and EQ-5D scores (all p < 0.05). During RRMM therapy, being female, with any comorbidity, ≥ 65 years old, and ≥ 5 years MM history, contributed to high symptoms burden and poor QOL status (each p < 0.05). MDASI-MM modules were sensitive to detect the RRMM-related symptoms burden, which correlated with objective clinical measures. RRMM patients reported a more compromised QOL.
datePublished:2020-05-11T00:00:00Z
dateModified:2020-05-11T00:00:00Z
pageStart:467
pageEnd:475
sameAs:https://doi.org/10.1007/s00520-020-05493-y
keywords:
Multiple myeloma
Refractory
Patient-reported outcomes
Quality of life
Symptom burden
Functional outcomes
Oncology
Nursing
Nursing Research
Pain Medicine
Rehabilitation Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00520-020-05493-y/MediaObjects/520_2020_5493_Fig1_HTML.png
isPartOf:
name:Supportive Care in Cancer
issn:
1433-7339
0941-4355
volumeNumber:29
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mona Kamal
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Ain Shams University
address:
name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
type:PostalAddress
type:Organization
type:Person
name:Xin Shelley Wang
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Qiuling Shi
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Teresa M. Zyczynski
affiliation:
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
type:Organization
type:Person
name:Catherine Davis
affiliation:
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
type:Organization
type:Person
name:Loretta A. Williams
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Hui-Kai Lin
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Araceli Garcia-Gonzalez
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Charles S. Cleeland
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Robert Orlowski
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma
description:Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of life in RRMM patients. The cross-sectional study included 184 MM patients (141 RRMM cases and 43 MM patients on follow-up without diagnosis/treatment of RRMM disease as controls), while 64 RRMM patients also provided longitudinal patient-reported outcomes (PROs) data. Symptomatic status was based on clinical measures of disease activity. PROs included the MD Anderson Symptom Inventory multiple myeloma module (MDASI-MM), single-item quality of life (SIQOL), and EuroQol-5D (EQ-5D). Wilcoxon rank test and effect size were used for comparisons. Regression models were used to describe symptom trajectory and to identify predictors of high symptom burden during 3 months of RRMM therapy. Most patients were clinically identified as symptomatic (93%). RRMM patients tended to report more severe symptoms, with significantly lower QOL scores and more severe fatigue, poor appetite, and lower enjoyment of life compared with controls (all p < 0.05). In RRMM patients, lower hemoglobin and higher B-2 microglobulin levels significantly correlated with higher burdens of fatigue, pain, and muscle weakness and also with lower QOL and EQ-5D scores (all p < 0.05). During RRMM therapy, being female, with any comorbidity, ≥ 65 years old, and ≥ 5 years MM history, contributed to high symptoms burden and poor QOL status (each p < 0.05). MDASI-MM modules were sensitive to detect the RRMM-related symptoms burden, which correlated with objective clinical measures. RRMM patients reported a more compromised QOL.
datePublished:2020-05-11T00:00:00Z
dateModified:2020-05-11T00:00:00Z
pageStart:467
pageEnd:475
sameAs:https://doi.org/10.1007/s00520-020-05493-y
keywords:
Multiple myeloma
Refractory
Patient-reported outcomes
Quality of life
Symptom burden
Functional outcomes
Oncology
Nursing
Nursing Research
Pain Medicine
Rehabilitation Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00520-020-05493-y/MediaObjects/520_2020_5493_Fig1_HTML.png
isPartOf:
name:Supportive Care in Cancer
issn:
1433-7339
0941-4355
volumeNumber:29
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mona Kamal
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Ain Shams University
address:
name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
type:PostalAddress
type:Organization
type:Person
name:Xin Shelley Wang
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Qiuling Shi
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Teresa M. Zyczynski
affiliation:
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
type:Organization
type:Person
name:Catherine Davis
affiliation:
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
type:Organization
type:Person
name:Loretta A. Williams
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Hui-Kai Lin
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Araceli Garcia-Gonzalez
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Charles S. Cleeland
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Robert Orlowski
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Supportive Care in Cancer
issn:
1433-7339
0941-4355
volumeNumber:29
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:Ain Shams University
address:
name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Mona Kamal
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Ain Shams University
address:
name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
type:PostalAddress
type:Organization
name:Xin Shelley Wang
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Qiuling Shi
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Teresa M. Zyczynski
affiliation:
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
type:Organization
name:Catherine Davis
affiliation:
name:Bristol-Myers Squibb
address:
name:Bristol-Myers Squibb, Princeton, USA
type:PostalAddress
type:Organization
name:Loretta A. Williams
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Hui-Kai Lin
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Araceli Garcia-Gonzalez
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Charles S. Cleeland
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Robert Orlowski
affiliation:
name:The University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Bristol-Myers Squibb, Princeton, USA
name:Bristol-Myers Squibb, Princeton, USA
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(174)
- What's the monthly money flow for https://www.springernature.com/gp/authors?
- Explore the financials of https://link.springernature.com/home/
- How profitable is https://order.springer.com/public/cart?
- Find out how much https://submission.nature.com/new-submission/520/3 earns monthly
- How much profit is https://www.springernature.com/gp/librarians/licensing/agc/journals making per month?
- How much does https://doi.org/10.1200/jco.2017.76.5032 net monthly?
- How much does https://doi.org/10.1200%2Fjco.2017.76.5032 make?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29341834?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Improvement%20in%20overall%20survival%20with%20carfilzomib%2C%20lenalidomide%2C%20and%20dexamethasone%20in%20patients%20with%20relapsed%20or%20refractory%20multiple%20myeloma&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2017.76.5032&volume=36&issue=8&pages=728-734&publication_year=2018&author=Siegel%2CDS&author=Dimopoulos%2CMA&author=Ludwig%2CH&author=Facon%2CT&author=Goldschmidt%2CH&author=Jakubowiak%2CA&author=San-Miguel%2CJ&author=Obreja%2CM&author=Blaedel%2CJ&author=Stewart%2CAK?
- What's the revenue for https://doi.org/10.1182/blood-2007-08-104984?
- What's the monthly income of https://doi.org/10.1182%2Fblood-2007-08-104984?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17901246 rake in every month?
- http://scholar.google.com/scholar_lookup?&title=Recent%20major%20improvement%20in%20long-term%20survival%20of%20younger%20patients%20with%20multiple%20myeloma&journal=Blood&doi=10.1182%2Fblood-2007-08-104984&volume=111&issue=5&pages=2521-2526&publication_year=2008&author=Brenner%2CH&author=Gondos%2CA&author=Pulte%2CD's revenue stream
- What's the total monthly financial gain of https://doi.org/10.1185/03007995.2015.1105202?
- How much does https://doi.org/10.1185%2F03007995.2015.1105202 gross monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26488820 income
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Real-world%20treatment%20patterns%2C%20comorbidities%2C%20and%20disease-related%20complications%20in%20patients%20with%20multiple%20myeloma%20in%20the%20United%20States&journal=Curr%20Med%20Res%20Opin&doi=10.1185%2F03007995.2015.1105202&volume=32&issue=1&pages=95-103&publication_year=2016&author=Song%2CX&author=Cong%2CZ&author=Wilson%2CK
- How much profit does https://doi.org/10.1016/j.jpainsymman.2012.11.003 make?
- Monthly income for https://doi.org/10.1016%2Fj.jpainsymman.2012.11.003
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Living%20with%20advanced%20but%20stable%20multiple%20myeloma%3A%20a%20study%20of%20the%20symptom%20burden%20and%20cumulative%20effects%20of%20disease%20and%20intensive%20%28hematopoietic%20stem%20cell%20transplant-based%29%20treatment%20on%20health-related%20quality%20of%20life&journal=J%20Pain%20Symptom%20Manag&doi=10.1016%2Fj.jpainsymman.2012.11.003&volume=46&issue=5&pages=671-680&publication_year=2013&author=Boland%2CE&author=Eiser%2CC&author=Ezaydi%2CY&author=Greenfield%2CDM&author=Ahmedzai%2CSH&author=Snowden%2CJA is on a monthly basis
- https://www.nccn.org/professionals/physician_gls/pdf/myeloma.pdf income
- Financial intake of https://doi.org/10.1007/s00520-018-4137-x
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29560502 pull in monthly?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Patient-reported%20outcomes%20in%20relapsed%2Frefractory%20multiple%20myeloma%3A%20a%20systematic%20review&journal=Support%20Care%20Cancer&doi=10.1007%2Fs00520-018-4137-x&volume=26&issue=7&pages=2075-2090&publication_year=2018&author=Sparano%2CF&author=Cavo%2CM&author=Niscola%2CP&author=Caravita%2CT&author=Efficace%2CF
- Monthly income for https://doi.org/10.1111/j.1600-0609.2012.01831.x
- Check the income stats for https://doi.org/10.1111%2Fj.1600-0609.2012.01831.x
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22762785 making per month?
- What's http://scholar.google.com/scholar_lookup?&title=Health-related%20quality%20of%20life%20and%20disease-specific%20complaints%20among%20multiple%20myeloma%20patients%20up%20to%2010%20yr%20after%20diagnosis%3A%20results%20from%20a%20population-based%20study%20using%20the%20PROFILES%20registry&journal=Eur%20J%20Haematol&doi=10.1111%2Fj.1600-0609.2012.01831.x&volume=89&issue=4&pages=311-319&publication_year=2012&author=Mols%2CF&author=Oerlemans%2CS&author=Vos%2CAH&author=Koster%2CA&author=Verelst%2CS&author=Sonneveld%2CP&author=Poll-Franse%2CLV's gross income?
- Earnings of https://doi.org/10.1111/j.1600-0609.2009.01303.x
- What is the earnings of https://doi.org/10.1111%2Fj.1600-0609.2009.01303.x?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19558508?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Health-related%20quality%20of%20life%20assessment%20in%20randomised%20controlled%20trials%20in%20multiple%20myeloma%3A%20a%20critical%20review%20of%20methodology%20and%20impact%20on%20treatment%20recommendations&journal=Eur%20J%20Haematol&doi=10.1111%2Fj.1600-0609.2009.01303.x&volume=83&issue=4&pages=279-289&publication_year=2009&author=Kvam%2CAK&author=Fayers%2CP&author=Hjermstad%2CM&author=Gulbrandsen%2CN&author=Wisloff%2CF
- How much revenue does https://doi.org/10.1002/sim.4780101207 produce monthly?
- What is the earnings of https://doi.org/10.1002%2Fsim.4780101207?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1805318 have monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Assessment%20of%20quality%20of%20life%20in%20clinical%20trials&journal=Stat%20Med&doi=10.1002%2Fsim.4780101207&volume=10&issue=12&pages=1915-1930&publication_year=1991&author=Schumacher%2CM&author=Olschewski%2CM&author=Schulgen%2CG produce monthly?
- Financial intake of https://doi.org/10.1186/1756-8722-6-13
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23384030 make?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598689's total income per month
- How much profit does http://scholar.google.com/scholar_lookup?&title=Validation%20of%20the%20M.%20D.%20Anderson%20Symptom%20Inventory%20multiple%20myeloma%20module&journal=J%20Hematol%20Oncol&doi=10.1186%2F1756-8722-6-13&volume=6&publication_year=2013&author=Jones%2CD&author=Vichaya%2CEG&author=Wang%2CXS&author=Williams%2CLA&author=Shah%2CND&author=Thomas%2CSK&author=Johnson%2CVE&author=Champlin%2CRE&author=Cleeland%2CCS&author=Mendoza%2CTR generate?
- How much income does https://doi.org/10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v have?
- How much income is https://doi.org/10.1002%2F1097-0142%2820001001%2989%3A7%3C1634%3A%3Aaid-cncr29%3E3.0.co%3B2-v earning monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11013380 gross monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Assessing%20symptom%20distress%20in%20cancer%20patients%3A%20the%20M.D.%20Anderson%20Symptom%20Inventory&journal=Cancer&doi=10.1002%2F1097-0142%2820001001%2989%3A7%3C1634%3A%3Aaid-cncr29%3E3.0.co%3B2-v&volume=89&issue=7&pages=1634-1646&publication_year=2000&author=Cleeland%2CCS&author=Mendoza%2CTR&author=Wang%2CXS&author=Chou%2CC&author=Harle%2CMT&author=Morrissey%2CM&author=Engstrom%2CMC have?
- Get to know what's the income of https://doi.org/10.1158/1078-0432.Ccr-03-0561
- How much income is https://doi.org/10.1158%2F1078-0432.Ccr-03-0561 earning monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15173093 gross monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Synergistic%20induction%20of%20oxidative%20injury%20and%20apoptosis%20in%20human%20multiple%20myeloma%20cells%20by%20the%20proteasome%20inhibitor%20bortezomib%20and%20histone%20deacetylase%20inhibitors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.Ccr-03-0561&volume=10&issue=11&pages=3839-3852&publication_year=2004&author=Pei%2CXY&author=Dai%2CY&author=Grant%2CS?
- How much does https://doi.org/10.1200/jco.2005.04.7779 bring in each month?
- How much income does https://doi.org/10.1200%2Fjco.2005.04.7779 have?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16754936 earns monthly
- How much profit does http://scholar.google.com/scholar_lookup?&title=Frequency%2C%20characteristics%2C%20and%20reversibility%20of%20peripheral%20neuropathy%20during%20treatment%20of%20advanced%20multiple%20myeloma%20with%20bortezomib&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2005.04.7779&volume=24&issue=19&pages=3113-3120&publication_year=2006&author=Richardson%2CPG&author=Briemberg%2CH&author=Jagannath%2CS&author=Wen%2CPY&author=Barlogie%2CB&author=Berenson%2CJ&author=Singhal%2CS&author=Siegel%2CDS&author=Irwin%2CD&author=Schuster%2CM&author=Srkalovic%2CG&author=Alexanian%2CR&author=Rajkumar%2CSV&author=Limentani%2CS&author=Alsina%2CM&author=Orlowski%2CRZ&author=Najarian%2CK&author=Esseltine%2CD&author=Anderson%2CKC&author=Amato%2CAA generate?
- How much revenue does https://seer.cancer.gov/statfacts/html/mulmy.html produce monthly?
- Get to know https://doi.org/10.1007/s00277-014-2264-0's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25471174 rake in every month?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Elderly%20multiple%20myeloma%20patients%20experience%20less%20deterioration%20in%20health-related%20quality%20of%20life%20than%20younger%20patients%20compared%20to%20a%20normative%20population%3A%20a%20study%20from%20the%20population-based%20PROFILES%20registry&journal=Ann%20Hematol&doi=10.1007%2Fs00277-014-2264-0&volume=94&issue=4&pages=651-661&publication_year=2015&author=Poel%2CMW&author=Oerlemans%2CS&author=Schouten%2CHC&author=Poll-Franse%2CLV
- What's the monthly money flow for https://doi.org/10.2337/diacare.26.4.1322-a?
- How much money does https://doi.org/10.2337%2Fdiacare.26.4.1322-a make?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12663627
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Thalidomide-associated%20hyperglycemia%20and%20diabetes%3A%20case%20report%20and%20review%20of%20literature&journal=Diabetes%20Care&doi=10.2337%2Fdiacare.26.4.1322-a&volume=26&issue=4&pages=1322-1323&publication_year=2003&author=Pathak%2CRD&author=Jayaraj%2CK&author=Blonde%2CL?
- How much income is https://doi.org/10.1002/cncr.22921 earning monthly?
- Profit of https://doi.org/10.1002%2Fcncr.22921
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17654660?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Neurotoxicity%20of%20bortezomib%20therapy%20in%20multiple%20myeloma%3A%20a%20single-center%20experience%20and%20review%20of%20the%20literature&journal=Cancer&doi=10.1002%2Fcncr.22921&volume=110&issue=5&pages=1042-1049&publication_year=2007&author=Badros%2CA&author=Goloubeva%2CO&author=Dalal%2CJS&author=Can%2CI&author=Thompson%2CJ&author=Rapoport%2CAP&author=Heyman%2CM&author=Akpek%2CG&author=Fenton%2CRG
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Relapsed%20or%20relapsed%2Frefractory%20multiple%20myeloma&journal=J%20Adv%20Pract%20Oncol&volume=4&issue=Suppl%201&pages=5-14&publication_year=2013&author=Kurtin%2CS?
- How much does https://doi.org/10.1111/j.1600-0609.2012.01775.x earn?
- What's the monthly money flow for https://doi.org/10.1111%2Fj.1600-0609.2012.01775.x?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22404182's earnings
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492844 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Thalidomide%20and%20dexamethasone%20vs.%20bortezomib%20and%20dexamethasone%20for%20melphalan%20refractory%20myeloma%3A%20a%20randomized%20study&journal=Eur%20J%20Haematol&doi=10.1111%2Fj.1600-0609.2012.01775.x&volume=88&issue=6&pages=485-496&publication_year=2012&author=Hjorth%2CM&author=Hjertner%2CO&author=Knudsen%2CLM&author=Gulbrandsen%2CN&author=Holmberg%2CE&author=Pedersen%2CPT&author=Andersen%2CNF&author=Andreasson%2CB&author=Billstrom%2CR&author=Carlson%2CK&author=Carlsson%2CMS&author=Flogegard%2CM&author=Forsberg%2CK&author=Gimsing%2CP&author=Karlsson%2CT&author=Linder%2CO&author=Nahi%2CH&author=Othzen%2CA&author=Swedin%2CA rake in every month?
- Earnings of https://doi.org/10.1186/s12885-016-2410-2
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27387201?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937527 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20impact%20of%20disease-related%20symptoms%20and%20palliative%20care%20concerns%20on%20health-related%20quality%20of%20life%20in%20multiple%20myeloma%3A%20a%20multi-centre%20study&journal=BMC%20Cancer&doi=10.1186%2Fs12885-016-2410-2&volume=16&publication_year=2016&author=Ramsenthaler%2CC&author=Osborne%2CTR&author=Gao%2CW&author=Siegert%2CRJ&author=Edmonds%2CPM&author=Schey%2CSA&author=Higginson%2CIJ pull in?
- How much profit does https://doi.org/10.1111/ejh.12790 make?
- Get to know https://doi.org/10.1111%2Fejh.12790's earnings
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27528496
- How much does http://scholar.google.com/scholar_lookup?&title=Prevalence%20of%20symptoms%20in%20patients%20with%20multiple%20myeloma%3A%20a%20systematic%20review%20and%20meta-analysis&journal=Eur%20J%20Haematol&doi=10.1111%2Fejh.12790&volume=97&issue=5&pages=416-429&publication_year=2016&author=Ramsenthaler%2CC&author=Kane%2CP&author=Gao%2CW&author=Siegert%2CRJ&author=Edmonds%2CPM&author=Schey%2CSA&author=Higginson%2CIJ make?
- Explore the financials of https://doi.org/10.1200/jco.2002.08.131
- https://doi.org/10.1200%2Fjco.2002.08.131's total income per month
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12011126?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20double-blind%2C%20placebo-controlled%20trial%20of%20recombinant%20human%20erythropoietin%2C%20epoetin%20beta%2C%20in%20hematologic%20malignancies&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2002.08.131&volume=20&issue=10&pages=2486-2494&publication_year=2002&author=%C3%96sterborg%2CA&author=Brandberg%2CY&author=Molostova%2CV&author=Iosava%2CG&author=Abdulkadyrov%2CK&author=Hedenus%2CM&author=Messinger%2CD
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9785330
- See how much http://scholar.google.com/scholar_lookup?&title=Impact%20of%20anemia%20and%20fatigue%20on%20quality%20of%20life%20in%20cancer%20patients%3A%20a%20brief%20review&journal=Med%20Oncol&volume=15&issue=Suppl%201&pages=S3-S7&publication_year=1998&author=Thomas%2CML makes per month
- What's the monthly income of https://doi.org/10.1186/1477-7525-12-35?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24618388's total income per month
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007827?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Mapping%20EORTC%20QLQ-C30%20and%20QLQ-MY20%20to%20EQ-5D%20in%20patients%20with%20multiple%20myeloma&journal=Health%20Qual%20Life%20Outcomes&doi=10.1186%2F1477-7525-12-35&volume=12&publication_year=2014&author=Proskorovsky%2CI&author=Lewis%2CP&author=Williams%2CCD&author=Jordan%2CK&author=Kyriakou%2CC&author=Ishak%2CJ&author=Davies%2CFE?
- What's the financial gain of https://doi.org/10.1046/j.1365-2141.1997.222667.x?
- Revenue of https://doi.org/10.1046%2Fj.1365-2141.1997.222667.x
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9136939
- How much income is http://scholar.google.com/scholar_lookup?&title=Health-related%20quality%20of%20life%20assessed%20before%20and%20during%20chemotherapy%20predicts%20for%20survival%20in%20multiple%20myeloma&journal=Br%20J%20Haematol&doi=10.1046%2Fj.1365-2141.1997.222667.x&volume=97&issue=1&pages=29-37&publication_year=1997&author=Wisl%C3%98ff%2CF&author=Hjorth%2CM earning monthly?
- How much profit does https://doi.org/10.1200/jco.2005.04.0824 generate?
- What is the earnings of https://doi.org/10.1200%2Fjco.2005.04.0824?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Descriptive%20and%20prognostic%20value%20of%20patient-reported%20outcomes%3A%20the%20bortezomib%20experience%20in%20relapsed%20and%20refractory%20multiple%20myeloma&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2005.04.0824&volume=4&issue=6&pages=976-982&publication_year=2006&author=Dubois%2CD&author=Dhawan%2CR&author=Velde%2CH&author=Esseltine%2CD&author=Gupta%2CS&author=Viala%2CM&author=Loge%2CC?
- What's the total monthly financial gain of https://doi.org/10.1016/j.jclinepi.2006.10.006?
- How much does https://doi.org/10.1016%2Fj.jclinepi.2006.10.006 pull in?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17573982?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Patient-reported%20outcomes%20helped%20predict%20survival%20in%20multiple%20myeloma%20using%20partial%20least%20squares%20analysis&journal=J%20Clin%20Epidemiol&doi=10.1016%2Fj.jclinepi.2006.10.006&volume=60&issue=7&pages=670-679&publication_year=2007&author=Viala%2CM&author=Bhakar%2CAL&author=Loge%2CC&author=Velde%2CH&author=Esseltine%2CD&author=Chang%2CM&author=Dhawan%2CR&author=Dubois%2CD
- What's the income generated by https://doi.org/10.1056/NEJMoa1516282 each month?
- What are the total earnings of https://doi.org/10.1056%2FNEJMoa1516282?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27119237?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Oral%20ixazomib%2C%20lenalidomide%2C%20and%20dexamethasone%20for%20multiple%20myeloma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1516282&volume=374&issue=17&pages=1621-1634&publication_year=2016&author=Moreau%2CP&author=Masszi%2CT&author=Grzasko%2CN&author=Bahlis%2CNJ&author=Hansson%2CM&author=Pour%2CL&author=Sandhu%2CI&author=Ganly%2CP&author=Baker%2CBW&author=Jackson%2CSR&author=Stoppa%2CAM&author=Simpson%2CDR&author=Gimsing%2CP&author=Palumbo%2CA&author=Garderet%2CL&author=Cavo%2CM&author=Kumar%2CS&author=Touzeau%2CC&author=Buadi%2CFK&author=Laubach%2CJP&author=Berg%2CDT&author=Lin%2CJ&author=Bacco%2CA&author=Hui%2CAM&author=Velde%2CH&author=Richardson%2CPG?
- Profit of https://doi.org/10.1056/NEJMoa1505654
- How much revenue does https://doi.org/10.1056%2FNEJMoa1505654 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26035255's financial summary
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Elotuzumab%20therapy%20for%20relapsed%20or%20refractory%20multiple%20myeloma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1505654&volume=373&issue=7&pages=621-631&publication_year=2015&author=Lonial%2CS&author=Dimopoulos%2CM&author=Palumbo%2CA&author=White%2CD&author=Grosicki%2CS&author=Spicka%2CI&author=Walter-Croneck%2CA&author=Moreau%2CP&author=Mateos%2CM-V&author=Magen%2CH&author=Belch%2CA&author=Reece%2CD&author=Beksac%2CM&author=Spencer%2CA&author=Oakervee%2CH&author=Orlowski%2CRZ&author=Taniwaki%2CM&author=R%C3%B6llig%2CC&author=Einsele%2CH&author=Wu%2CKL&author=Singhal%2CA&author=San-Miguel%2CJ&author=Matsumoto%2CM&author=Katz%2CJ&author=Bleickardt%2CE&author=Poulart%2CV&author=Anderson%2CKC&author=Richardson%2CP?
- What is the monthly revenue of https://doi.org/10.1200/JCO.2016.66.9648?
- Earnings of https://doi.org/10.1200%2FJCO.2016.66.9648
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27601539's financial summary
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791840 pull in?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Health-related%20quality-of-life%20results%20from%20the%20open-label%2C%20randomized%2C%20phase%20III%20ASPIRE%20trial%20evaluating%20carfilzomib%2C%20lenalidomide%2C%20and%20dexamethasone%20versus%20lenalidomide%20and%20dexamethasone%20in%20patients%20with%20relapsed%20multiple%20myeloma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2016.66.9648&volume=34&issue=32&pages=3921-3930&publication_year=2016&author=Stewart%2CAK&author=Dimopoulos%2CMA&author=Masszi%2CT&author=%C5%A0pi%C4%8Dka%2CI&author=Oriol%2CA&author=H%C3%A1jek%2CR&author=Rosi%C3%B1ol%2CL&author=Siegel%2CDS&author=Niesvizky%2CR&author=Jakubowiak%2CAJ&author=San-Miguel%2CJF&author=Ludwig%2CH&author=Buchanan%2CJ&author=Cocks%2CK&author=Yang%2CX&author=Xing%2CB&author=Zojwalla%2CN&author=Tonda%2CM&author=Moreau%2CP&author=Palumbo%2CA
- What's the profit of https://doi.org/10.1111/j.1365-2141.2008.07378.x?
- How much does https://doi.org/10.1111%2Fj.1365-2141.2008.07378.x rake in every month?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18986387?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Bortezomib%20is%20associated%20with%20better%20health-related%20quality%20of%20life%20than%20high-dose%20dexamethasone%20in%20patients%20with%20relapsed%20multiple%20myeloma%3A%20results%20from%20the%20APEX%20study&journal=Br%20J%20Haematol&doi=10.1111%2Fj.1365-2141.2008.07378.x&volume=143&issue=4&pages=511-519&publication_year=2008&author=Lee%2CSJ&author=Richardson%2CPG&author=Sonneveld%2CP&author=Schuster%2CMW&author=Irwin%2CD&author=San%20Miguel%2CJF&author=Crawford%2CB&author=Massaro%2CJ&author=Dhawan%2CR&author=Gupta%2CS&author=Anderson%2CKC?
- What's the revenue for https://doi.org/10.3324/haematol.2012.075051?
- What are the total earnings of https://doi.org/10.3324%2Fhaematol.2012.075051?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23445873 make?
- Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669456
- How much does http://scholar.google.com/scholar_lookup?&title=Age%20and%20organ%20damage%20correlate%20with%20poor%20survival%20in%20myeloma%20patients%3A%20meta-analysis%20of%201435%20individual%20patient%20data%20from%204%20randomized%20trials&journal=Haematologica&doi=10.3324%2Fhaematol.2012.075051&volume=98&issue=6&pages=980-987&publication_year=2013&author=Bringhen%2CS&author=Mateos%2CMV&author=Zweegman%2CS&author=Larocca%2CA&author=Falcone%2CAP&author=Oriol%2CA&author=Rossi%2CD&author=Cavalli%2CM&author=Wijermans%2CP&author=Ria%2CR&author=Offidani%2CM&author=Lahuerta%2CJJ&author=Liberati%2CAM&author=Mina%2CR&author=Callea%2CV&author=Schaafsma%2CM&author=Cerrato%2CC&author=Marasca%2CR&author=Franceschini%2CL&author=Evangelista%2CA&author=Teruel%2CA-I&author=Holt%2CB&author=Montefusco%2CV&author=Ciccone%2CG&author=Boccadoro%2CM&author=Miguel%2CJS&author=Sonneveld%2CP&author=Palumbo%2CA generate monthly?
- Revenue of https://doi.org/10.1080/17474086.2019.1645005
- How much revenue does https://doi.org/10.1080%2F17474086.2019.1645005 generate?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31317793 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Towards%20the%20integration%20of%20patient-reported%20outcomes%20into%20the%20global%20clinical%20management%20of%20multiple%20myeloma&journal=Expert%20Rev%20Hematol&doi=10.1080%2F17474086.2019.1645005&volume=12&issue=9&pages=703-705&publication_year=2019&author=Niscola%2CP&author=Scaramucci%2CL&author=Efficace%2CF earn?
- How much does https://doi.org/10.1200/jco.2014.55.1028 generate monthly?
- How much does https://doi.org/10.1200%2Fjco.2014.55.1028 pull in monthly?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25071143 making per month?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129503?
- How much does http://scholar.google.com/scholar_lookup?&title=Multiple%20myeloma%20in%20the%20older%20adult%3A%20better%20prospects%2C%20more%20challenges&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2014.55.1028&volume=32&issue=24&pages=2531-2540&publication_year=2014&author=Wildes%2CTM&author=Rosko%2CA&author=Tuchman%2CSA earn?
- Learn about the earnings of https://doi.org/10.1200/jco.2008.20.8983
- Earnings of https://doi.org/10.1200%2Fjco.2008.20.8983
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19403886 income
- How much does http://scholar.google.com/scholar_lookup?&title=Future%20of%20cancer%20incidence%20in%20the%20United%20States%3A%20burdens%20upon%20an%20aging%2C%20changing%20nation&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2008.20.8983&volume=27&issue=17&pages=2758-2765&publication_year=2009&author=Smith%2CBD&author=Smith%2CGL&author=Hurria%2CA&author=Hortobagyi%2CGN&author=Buchholz%2CTA bring in each month?
- See how much https://citation-needed.springer.com/v2/references/10.1007/s00520-020-05493-y?format=refman&flavour=references makes per month
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mona%20Kamal make?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mona%20Kamal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xin%20Shelley%20Wang?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xin%20Shelley%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qiuling%20Shi net monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qiuling%20Shi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Teresa%20M.%20Zyczynski
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Teresa%20M.%20Zyczynski%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Catherine%20Davis rake in every month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Catherine%20Davis%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Loretta%20A.%20Williams's earnings
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Loretta%20A.%20Williams%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hui-Kai%20Lin make?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hui-Kai%20Lin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Araceli%20Garcia-Gonzalez
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Araceli%20Garcia-Gonzalez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Charles%20S.%20Cleeland?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Charles%20S.%20Cleeland%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20Orlowski
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20Orlowski%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- https://s100.copyright.com/AppDispatchServlet?title=Symptom%20burden%20and%20its%20functional%20impact%20in%20patients%20with%20%E2%80%9Csymptomatic%E2%80%9D%20relapsed%20or%20refractory%20multiple%20myeloma&author=Mona%20Kamal%20et%20al&contentID=10.1007%2Fs00520-020-05493-y©right=Springer-Verlag%20GmbH%20Germany%2C%20part%20of%20Springer%20Nature&publication=0941-4355&publicationDate=2020-05-11&publisherName=SpringerNature&orderBeanReset=true's financial summary
- What's https://crossmark.crossref.org/dialog/?doi=10.1007/s00520-020-05493-y's gross income?
- Profit of https://citation-needed.springer.com/v2/references/10.1007/s00520-020-05493-y?format=refman&flavour=citation
- Revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What are the total earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much income is https://www.springernature.com/gp/products earning monthly?
- https://www.springernature.com/gp/librarians's financial summary
- What's the income generated by https://www.springernature.com/gp/societies each month?
- How much income does https://www.springernature.com/gp/partners have?
- How much profit does https://www.springer.com/ generate?
- How much does https://www.nature.com/ bring in each month?
- Explore the financials of https://www.biomedcentral.com/
- What is the earnings of https://www.palgrave.com/?
- Get to know what's the income of https://www.apress.com/
- What's the income generated by https://www.springernature.com/gp/legal/ccpa each month?
- Explore the financials of https://www.springernature.com/gp/info/accessibility
- What's the monthly income of https://support.springernature.com/en/support/home?
- How much income is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations earning monthly?
- What is the earnings of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref